Cancer is one of the leading causes of death in the world. Although certain cancers can be cured initially, following the diagnosis of cancer, chemotherapy is frequently used to prevent a local recurrence and spread of the primary tumor. However, in the absence of effective adjuvant therapies new effective therapeutic regimens are needed. We invite authors to submit original research and review articles that cover the significant developments in the fields of novel medicines or strategies in cancer treatment and prevention including the discovery of novel anticancer, antimetastasis, or antiangiogenesis medicines and new strategies in cancer prevention. Potential topics include, but are not limited to:

• New anticancer agents
• Novel strategies in cancer treatment
• New antimetastasis agents
• Novel antiangiogenesis medicines
• New strategies in cancer prevention

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/biochemistry/ctp/ according to the following timetable: